No Data
No Data
Investors Appear Satisfied With Guangdong HEC Technology Holding Co., Ltd's (SHSE:600673) Prospects As Shares Rocket 51%
The sudden outbreak of H1N1 has ignited the sector against influenza, with HEC CJ PHARM (01558), holding the king of influenza, ready to take action.
Among the sample companies selling Oseltamivir formulations in the domestic market, HEC CJ PHARM's "Kewei" series products consistently maintain the top market share. As the influenza epidemic continues to escalate, HEC CJ PHARM's stock, being a key symbol in the Hong Kong stock market against Influenza, is also set to rise.
Returns On Capital Signal Difficult Times Ahead For Guangdong HEC Technology Holding (SHSE:600673)
Hong Kong stocks movement | HEC CJ PHARM (01558) rises over 6% as the high incidence of influenza boosts the sales of Oseltamivir and other medications.
HEC CJ PHARM (01558) rose over 6%, as of the time of reporting, up 6.54%, trading at 9.94 HKD, with a transaction amount of 21.0847 million HKD.
Hefei Taihe Intelligent Technology Group (603656.SH) controlling shareholder Guangdong Hec Technology Holding has cumulatively increased its Shareholding by 1%.
Hefei Taihe Intelligent Technology Group (603656.SH) announced that the company's controlling shareholder Guangdong Hec Technology Holding will be holding shares until December 27, 2024...
Is "The king of optical modules" taking action? Fenghe Yinghui acquires 5% of Guangdong Hec Technology Holding shares, who are the shareholders behind it?
Since the market trends of 924, many listed companies have seen valuation recovery, and under active market trading, there are no shortages of Institutional investors entering to seize opportunities. On the evening of December 23, Guangdong Hec Technology Holding (600673.SH) disclosed an announcement showing that its controlling Shareholder, Shenzhen Dongyangguang Industrial's concerted action partner, Chongqing Element Private Securities Investment Fund Management Co., Ltd. (representing the "Element Yuanyuan Private Securities Investment Fund") (hereinafter referred to as "Element Fund") sold its holdings of 150,693,800 shares of the company’s freely tradable stock (accounting for 5.00% of the company’s current total equity) at a price of 8.33 yuan/share through an agreement.